Search

The author reflects on the Crizotinib therapy associated with the hypogonadism. He informs that the Crizotinib is a small molecule of tyrosine kinase inhibitor and recently approved by the U.S. Food and Drug Administration for the treatment of patients who are suffering from advanced nonsmall cell lung cancer (NSCLC). He also opines that the Crizotinib therapy is one of the effective and safe treatments for patients suffering from lung cancer.

The article presents a policy brief on the regulation of electronic nicotine delivery systems and tobacco products by the U.S. Food and Drug Administration (FDA) from the American Society of Clinical Oncology (ASCO). Topics include the increasing popularity of electronic cigarettes (e-cigarettes) in the U.S., the need for health warnings on product packages and advertisements, and the absence of preventive measures to safeguard young children.